AbCellera
A Principal Scientist in Non-Clinical Safety at AbCellera is a senior scientific leader focused on advancing nonclinical safety for antibody-based medicines across discovery and clinical development. The position provides scientific leadership to ensure robust nonclinical strategies that support regulatory submissions and program advancement.
Headquarters
Vancouver, British Columbia, Canada
Company Size
501-1000 employees
Founded
2012
AbCellera is a biotechnology company that discovers and develops therapeutic antibodies using a proprietary high-throughput single‑cell screening platform combined with machine learning and large immune datasets. It partners with pharma and biotech to rapidly identify and optimize antibody leads and also advances its own pipeline of first‑in‑class and best‑in‑class programs across multiple indications and modalities. The platform is designed to accelerate target‑to‑candidate timelines and has been used in rapid-response collaborations and clinical‑stage antibody programs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbCellera.
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn
Dec 25, 2025
Senior Principal Scientist / Associate Director, Toxicology
Orum Therapeutics
Principal Scientist, Toxicology
CSL
Principal Scientist, Toxicology
Dyne Therapeutics
Principal Scientist, Regulatory Toxicology
CSL
Director, Toxicology
Praxis Precision Medicines, Inc.
Sr. Scientist II, Toxicology
oraclecloudinfrastructure